NTRK1 and non-small cell lung carcinoma: In a clinical setting, patients with non-small cell lung carcinoma (NSCLC), circulating tyrosine kinase receptor TIE2hi expressing M-MDSCs were found to suppress antigen-specificT cell responses and their presence was linked to poor patient outcomes (58).